In summary, to our knowledge, this report is the first to describe the association between the combined effects of genetic variants of the PTEN, AKT1, MDM2 and p53 tumor suppressor-oncoprotein network and the risk of NPC. The gene discussed is TP53; the disease is nasopharyngeal carcinoma.